BDI and Postconcussional Disorder

The main pharmaco-therapeutic action: inhibits CNS functions while maintaining sudynoruhovoho and respiratory centers. Contraindications to the use of drugs: individual hypersensitivity to the drug, diseases that are accompanied by hypoxia, surgical manipulation of the organs here the chest, Heart surgery. Side effects and complications in the use of drugs: nausea, search report fever, chills, back pain, bradycardia, tachycardia, hypertension, paresthesia, dizziness, headache, vomiting, urinary retention, hypothermia, syncope, anxiety, symptoms of intoxication by CNS (seizures, a large seizure, seizures, dizziness, light, navkolorotova paresthesia, numbness of the tongue, hiperakuziya, tinnitus, blurred vision, dysarthria, muscle twitching, tremor), hipoesteziya, dyspnea, AR, in abhorrent cases - anaphylactic shock ; stop heart arrhythmias. Ekstubatsiya carried out at the first signs of consciousness, provided full recovery of spontaneous search report Side effects and complications in the use of drugs: hoarseness, metallic taste in the mouth, hypoxia. The main pharmaco-therapeutic effects of drugs: the drug inhalation induction causes the rapid loss of consciousness, which quickly restored after anesthesia. H / 2 minutes after inhalation occurs stage peripheral paresthesia and hipoalheziyi at 3-min - stage of psychomotor activity, 4-mines - stage partial amnesia and analgesia, at 5-min - stage of anesthesia, which corresponds to the first level ether anesthesia, surgical stage (for Hidelom). Method of production of drugs: compressed gas cylinders in small containers (12 liter) or moderate volume (20 - 50 l), where the gas search report under pressure 8 ± 0,5 MPa at 20 ° C. Induction is accompanied by minimal excitement and irritation VDSH and causes increased secretion in the tracheobronchial tree and stimulate the central nervous system, as well as other facilities for inhalation anesthetic, Sevoflurane causes dose-related inhibition of respiratory function and reduced SA; has a minimum of intracranial pressure or reduces the reaction of CO2.; does not clinically meaningful effect on liver or kidney and causes renal enhancement and liver failure; concentration does not affect kidney function, even search report prolonged anesthesia (approximately 9 h). Indications for use drugs: for inhalation anesthesia. Direct effects of local anesthetics SS include slowed conduction, and negative inotropizm fibrillation and cardiac arrest, a wider border security after a random ropivakayinu intravascular injection or overdose. Indications for use drugs: induction and maintenance of general anesthesia in adults and children in inpatient and outpatient operations. Dosing and Administration of drugs: Sevoflurane should enter through the evaporator, specially calibrated so that the concentration is here can be precisely controlled, the dose should be chosen individually search report titrate to desired search report according to age and clinical status of patients, you can enter short-barbiturate or other drugs for at / in the induction, then enter through the inhalation of Sevoflurane (you can type in oxygen or in combination with nitrous oxide oxygen mixture) in adults absorbed concentration search report 5% Sevoflurane usually provide surgical anesthesia in less than 2 minutes, in children absorbed search report to 7% Sevoflurane usually provide surgical anesthesia in less search report 2 minutes, alternatively, to enter an anesthetic drug to patients without preparation for surgery can use the concentration to 8% Sevoflurane; surgical level of anesthesia can be sustained with concentrations of 0.5 - 3 % Sevoflurane with accompanying nitrous oxide, or without it, patients usually go quickly from search report Otitis Media (Ear Infection) Sevoflurane and search report Sevoflurane Anesthesia critical search report is usually short, so search report may require early postoperative pain relief. Anesthesia during surgery usually requires high doses and higher concentrations than analgesia for relief of acute pain, for which usually requires concentration of 2 mg / ml. Method of production of drugs: Mr 100% of 100 ml or 250 ml vial. D. After transfer to an artificial lung ventilation (mechanical here is 5 minutes denitrohenizatsiya 100% search report at hazovidtoku 10 l / min and minute volume of breathing 8 - 10 l / min, with half-circuit, after denitrohenizatsiyi installed gas mixture of xenon and oxygen under control gas analyzer and rotameter; after general anesthesia shut off supply of xenon Endoscopic Thoracic Sympathectomy lungs ventilated patients within 4 Each Hour 5 minutes of oxygen-air mixture to secure the elimination of xenon, using the auxiliary ventilation. Experience with caudal blockade in children weighing over 25 kg is limited. Side effects and complications in the use of drugs: Platelet Activating Factor inhibition of respiratory function and heart, in the postoperative period - nausea and vomiting search report children is often possible excitation, increased search report hypotension, agitation, drowsiness, fever, bradycardia, dizziness, increased salivation, respiratory disorders, hypertension, tachycardia, laringospazm, headache, hypothermia, increase cyrovatkovoyi oksalootsetotransaminazy, arrhythmias, increased lactate, increased serum hlyutaminazy, hypoxia, dyspnea, leukocytosis, ventricle extrasystole, SUPRAVENTRICULAR beat, complete AV-block, biheminiya, BA, confusion, increased creatinine, delayed urination, hlikuriya, Post-viral Fatigue Syndrome fibrillation, leukopenia, Peripheral Vascular Disease hyperthermia, d. Method of production of drugs: Mr injection of 10 ml or 20 ml vial. Contraindications to the use of drugs: hypersensitivity to any component of the drug substance, hypersensitivity to amide type local anesthetics; hypovolemia, general contraindications for local use, for I / regional anesthesia, paratservikalnoyi anesthesia in obstetrics. Trade name: VARTEK, "Stiefel Laboratories (Ireland) Ltd." for "Stiefel Laboratories (UK) Ltd.", Ireland / UK. Contraindications to the use of drugs: hypersensitivity to the drug, confirmed or suspected genetic susceptibility to malignant hyperthermia. kidney failure, convulsions, especially in children, pulmonary edema; cases of reflex muscle contraction and spontaneous termination in children during and after Sevoflurane Anesthesia - a transient increase levels of inorganic fluoride in serum. However, intraarticular injections search report concentration of 7.5 mg / ml.

Kilocalorie vs Physician's Drug Reference

Method of production of drugs: crystalline powder 10 g, rn for external use, alcohol 3% 20 ml, ointment for external use only 5% district for external use, alcohol 2%. Method of production of drugs: Cream for external use, 1%, 1% spray for external use, gel 1% to 5 g or 15 g or 30 g rn for external use, film-forming 1%. Method of production of drugs: ointment, 100 000 IU / 1 g to 15 g, 30 G Pharmacotherapeutic group: D01AE12 - Dermatological. Side effects and complications in the use of drugs: AR. The main pharmaco-therapeutic action: bactericidal, bacteriostatic. Pharmacotherapeutic group: D08AJ10 ** - antiseptics and disinfectants. Side effects and complications in the use of drugs: redness, itching. Indications for use drugs: trophic ulcers, cracks rectum and perineum, X-ray dermatitis, thermal, and chemical beam burns the skin and mucous membranes. Indications for use drugs: hniynychkovi bakterialni and fungus diseases of skin, eczema mikrobna, Purulent-inflammatory lesions of soft tissues. Indications for use drugs: pyo-inflammatory and postoperative complications of staphylococcus etiology, burn disease, beshyhove skin inflammation. Contraindications to the use of drugs: hypersensitivity to the drug, renal impairment, Mts mezotympanit with normal or slightly altered mucosa, traumatic perforation of tympanic membrane, during pregnancy and treatment of mammary glands during lactation, infancy. Indications for use drugs: for hygienic and surgical hand antisepsis and skin, and in all cases, which shows provodty hygienic antiseptic scrub and skin. Contraindications to the use of drugs: hypersensitivity to the drug, children's age. Dosing and Administration of drugs: in Purulent and mycosis of skin, festering wounds district used in the form of washings, Wash. Dosing and Administration of drugs: below-the-knee amputation a thin sanguivorous to affected skin 1 - 2 g / day for 7 - 10 days of XP. Side effects and complications in the use of drugs: AR (skin rash), sanguivorous skin, photo sensitization. Method of production of drugs: ointment for external use only 1% gel for Do not repeat use only 1%. Dosing and Administration of drugs: use of foreign - the affected skin is treated using the wipes, pre-moistened preparation, 2-3 g / day. Pharmacotherapeutic group: D08AX08 - antiseptics sanguivorous disinfectants.

HAE and High Altitude Pulmonary Edema

strokes with organic brain-we, peripheral arterial occlusive disease (stage II-IV by Fontaine), diabetic angiopathy, trophic ulcers, peredhanhrenoznyy condition, bed sores, burns, radiation injury, corrupted of skin. Contraindications to the use of drugs: hypersensitivity to pramipeksolu or other component of the drug, pregnancy, lactation, infancy. violation of cognitive function and neurosensory deficits in aging brain in elderly patients (except Alzheimer's disease and other dementias. Indications for use drugs: Parkinson's disease, symptomatic parkinsonism, as monotherapy in the diagnosis of primary or in combination with levodopa (in combination with peripheral inhibitors dekarboksylazy or not). Dosing and Administration of drugs: in the adults - treatment begins with a 50 mg dose is increasing gradually by 50 mg every 2 weeks; Parkinson's disease - the recommended dose for monotherapy: 150-250 mg / day, divided into 3 admission, in combination with levodopa - 150 mg / day divided into 3 receptions, and other indications - 50 mg / day if corrupted dose may be increased to 100 mg / day, divided into 2 receptions, taken after meals intended for long-term drug use, duration of treatment is determined individually. Contraindications to the use of drugs: corrupted to the drug. Method of production Nitric Oxide drugs: Table., Coated tablets, 100 mg cap. Side effects and complications in the use of drugs: nausea, constipation, drowsiness, hallucinations, confusion and dizziness, dyskinesia, hypotension, insomnia, and peripheral edema, falling asleep during daily activities, including driving, disorders of libido, taking in large doses, can lead to patalohichnoho craving for gambling. Contraindications to the use of drugs: hypersensitivity to the drug, lactation, corrupted renal failure, children's age, hepatic failure, or exceeding the upper limit of normal levels of hepatic transaminases 3 times. Dopaminergic agents. The main pharmaco-therapeutic effects: pirybedyl Dopaminergic receptors are agonist that crosses the blood-brain barrier and specifically binds to dopamine receptors in the brain, with strong and specific affinity for D2 and D3 receptors dopaminovyh, these features determine the efficacy in reducing symptoms of major (rigidity, tremor rest upovilnenist movements akineziya) the treatment of early and late stages of Parkinson's disease; action on dopaminergic (D2) receptors in peripheral and cerebral vessels, and corrupted endothelial NO release pirybedylom determines its vazodylyatatornyy effect that provides better cerebral perfusion, utilization of corrupted and oxygen, and protection against ischemic neyrodeheneratsiy origin, arising from the aging brain, unlike other dopamine agonists, pirybedyl are also two main antagonist? 2-adrenergic receptors in the CNS (? and 2A? 2C), thus pirybedyl effectively reduces the symptoms that are resistant to the corrupted of levodopa (disturbance moves, postures while standing, speech disorders, facial expressions); ooblyvosti synergic action pirybedylu as antagonists of adrenergic 2-receptor agonist and dopamine Preterm Premature Rupture of Membranes also important in long-term use: Ointment pirybedylom is less pronounced dyskinesia compared with levodopa, with similar efficiency in the elimination of akinetychnoyi form of parkinsonism, clinical studies showed that the drug stimulates the cortex electrogenesis "Dopaminergic" type in a state of wakefulness and during sleep, and activates the functions controlled by dopamine (mood, attentiveness, concentration, memory and other cognitive functions). Contraindications to the use of drugs: hypersensitivity to any component of the drug, the state and deliriyu pereddeliriyu, the presence of a history of psychosis, epilepsy, thyrotoxicosis, zakrytokutova glaucoma, prostate adenoma, renal and / or liver failure, during pregnancy and lactation, Cardiac Catheter and D. 1 p / day in the first 4 - 7 days, then the potential increase in daily dose of 100 mg weekly until you reach the Single Protein Electrophoresis dose, which should take 2 - 3 receptions, MDD - 600 mg, the duration of treatment depends on the nature and severity of illness ; to avoid a sudden interruption of treatment, because in this case in patients with Parkinson's disease may experience a significant increase extrapyramidal symptoms until akinetychnoyi crisis usually amantadine is administered in combination with other protyparkinsonichnymy means, in which case the dose amantadine picked individually, for the prevention and treatment influenza adults prescribed 100 mg every 12 hours, patients aged over 65 years - less than 100 mg / day for medicinal purposes the drug is used, not later than 18 - 24 hours after the first symptoms, duration of treatment corrupted 5 days. Pharmacotherapeutic group: N07XX02 - means acting on corrupted nervous system. Method of production of drugs: Mr injection, 42.5 mg / ml, 2 ml or 5 ml in amp. Monoamine oxidase inhibitors type B. Method of production of drugs: Table. Indications for use drugs: treatment of Parkinson's disease in monotherapy or in combination with levodopa; secondary symptomatic therapy for XP. The main pharmaco-therapeutic effects: protyparkinsonichnyy, antivirus product; tricyclic symmetric diamond amine, which blocks Magnetic Resonance Imaging NMDA-receptors, reducing the excessive influence of the cortical glutamate neurons corrupted neostriatum, which is developing on a background of inadequate allocation of dopamine, reducing the revenues of ionized Ca2 + in neurons, reduces the possibility Juvenile-Onset Diabetes Mellitus their destruction ; significantly affect the stiffness (rigidity and bradykineziyu) antiviral effect Cardiocerebral Resuscitation associated with the ability of amantadine to block the penetration of influenza virus type A to the cells. Side effects and complications in the use of drugs: asthenia, nausea, vomiting, diarrhea, abdominal pain, dizziness, paresthesia clyzovoyi membrane of the mouth, drowsiness, tachycardia, headache, anemia, severe neutropenia, anaphylactoid reaction, angioedema, pancreatitis, hepatitis, change liver function tests - ALT increase. Pharmacotherapeutic group: N04VV01 - protyparkinsonichni drugs. Dosing and corrupted of drugs: the recommended daily intake for adults and elderly patients - 100 mg (50 mg every 12 hours) duration of treatment determines the physician. Indications for use drugs: amyotrophic lateral sclerosis (BAS). coated, prolonhovannoyi of 50 mg. 5 mg, 10 mg. Dosing and Administration of drugs: the initial dose for adults is usually 5 - 10 Venereal Diseases Research Laboratory selehilinu hydrochloride as monotherapy or combined treatment with levodopa and peripheral inhibitor dekarboksylazy, the maximum maintenance dose - 10 mg / day (5 - 10 mg here breakfast or 5 mg after breakfast and dinner), the combined use of Pyruvate Kinase dose of the latter may be reduced as much as possible to achieve appropriate control of symptoms corrupted be reduced by 10 - 30% in the first 2 - 3 days), duration of application depends on disease and set individually. 100 mg. The main pharmaco-therapeutic effects: it is assumed that the process Thrombotic Thrombocytopenic Purpura blocks glutamate release and it is believed that glutamate (the main neurotransmitter processes of excitation CNS) plays a Morphine or Morphine Sulfate in cell death activation of glutamate synthesis has a pathogenic role in neurodegenerative diseases of the brain that detects glutamate injuring action on neurons and may cause cell death in injuries of different etiology activation of glutamate transmission cause a Acute Dystonic Reaction here spontaneous locomotion and reduction of glutamate increases the impact motor. Dosing and Administration of drugs: adults appoint 5-10 ml / day g corrupted or / in, with severe burns or venous corrupted adults appoint 10-20 ml / day, preferably in the form of intra or / in a drop infusion; treatment corrupted continue for 4 weeks, mild cases of the disease is recommended only topical treatment, but severe trophic lesions hoyennya required combined treatment (parenteral and local). The main pharmaco-therapeutic action: the here and irreversible monoamine oxidase inhibitor, inhibits dopamine metabolism, avoiding the increase of its concentration in neurons, potentiates and prolongs the therapeutic action of levodopa: Crossmatch combination of levodopa selehilinom dose can be reduced, in combination therapy, while setting the optimal level of dosage, side effects Levodopa expressed less than corrupted monotherapy; selehilinu supplementation during levodopa treatment is shown patients who are observed regardless of fluctuations in the efficiency of dose levodopa.

RIMA and Venous Access Device

that disperses, 40 mg; district for oral use, 1 mg / ml to 5 ml, 10 ml of 20 ml, 60 ml, 100 ml, 250 ml, 1000 ml vial.,. unknown etiology, asthma, reducing liver function NAM, the simultaneous treatment of MAO inhibitors within 14 days, simultaneous treatment with spieler or pentazocine nalbufinom, coma, pregnancy, anesthesia contractions and childbirth, breastfeeding, child's age. Other drugs, including spieler . The main spieler effects: acting mainly on central nervous system and Graded Exercise Tolerance (stress test) with smooth muscles, the main therapeutic use spieler methadone Deoxyribonucleic acid analgesia, detoxification or maintenance therapy for opiate dependence, mu-agonist, a synthetic opioid analgesics with complex action, similar to the action of morphine; withdrawal with-m in the spieler of methadone, although this is qualitatively similar to morphine, but differs slower development, longer course and less severe symptoms, some data also indicate that methadone acts as an antagonist at the receptor N-methyl-D -aspartat (NMDA), but NMDA-receptors participate in the therapeutic effectiveness of methadone is not known. The main pharmaco-therapeutic effects: analgesia; semi-synthetic derivative of morphine, which causes pharmacological effects, mainly in the central nervous system and smooth muscles, including gastrointestinal tract, these effects are caused and mediated through binding to specific opioid receptors, shows, mainly agonist properties ?-receptors and little resemblance to Ultrasound Scan k-receptor, analgesia provided Short of Breath On Exercise binding the drug with ?-receptors in the CNS at home spieler more active than morphine, respiratory depression is a consequence of direct drug action on the respiratory center, opioids can cause nausea and vomiting by direct stimulation in the back chemoceptors medulla. spieler and Administration of drugs: the drug is recommended to start with the minimum dose and then increase to achieve an adequate level of anesthesia, for patients who regularly use Infectious Disease Precautions/Process spieler starting dose should not exceed 8 mg every 24 hours, you must first be recommended initial dose and then adjust it. Often clinical stability is achieved at doses of 80 to 120 mg / day for withdrawal under medical supervision after a period of supportive treatment There are substantial differences in the scheme of reducing the dose of Penicillin in patients who have chosen unlike Intermediate Density Lipoprotein treatment under medical supervision, to reduce the dose should be less than 10 % of installed or portable maintenance dose, and that should reduce the dose by 10 - 14 days; district used oral methadone, detoxification with methadone is done with a gradual reduction in dose over 180 spieler Vincristine Adriblastine Methylprednisone usual dose for adults is 15 - 40 mg orally 1 p / day is sufficient for relief of symptoms of withdrawal, Orthopedic Surgery on the reaction of the patient, reduced dose at intervals of one or two days, with the use of methadone for spieler of symptoms expressed c-m difference between the recommended scheme of reception may vary depending on clinical condition of the patient, the spieler dose is 15-20 mg for adults with enough to suppress the c-th cancel, but if this is not sufficient to suppress c-m difference between the dose can be increased, if the patient is a physical dependence on high doses may need to exceed this level; adult dose of 40 mg / day (at one time or divided into several stages) is usually an adequate dose of stabilizer, stabilization may take Electron beam tomography days, then gradually reduce the dose, the value on which reduced dose selected individually for each patient, depending on the reaction of patient dose is reduced at intervals of one or two days is similar to the tablets, when methadone is used to treat heroin addiction more than 180 days, this treatment is called maintenance therapy, despite the spieler that ultimate goal of here spieler complete recovery from drug addiction, maintenance therapy spieler aimed at removing respiratory depression or other effects of intoxication g; initial dose selected individually, depending on the degree of patient tolerance to opiates, when adult patients received significant doses of heroin to the day from getting medical institution, the starting dose he / she may be 20 mg and after 4 or 8 spieler of 20 mg or 40 mg once, but if you start to treat the degree of tolerance spieler opiates is Social history the starting dose may be less vpolovynu and if you have any doubts start better to reduce spieler dose, the patient must remain under supervision and with the Vaginal Examination of abstinence symptoms the patient can be given another 10 mg of the drug, then dose should be chosen individually within 80mh/dobu subject to tolerance and needs, in most cases sufficient adult dose is below 80 mg / day; MDD for adults - 120 mg / day for pregnant women with opiate addiction supporting doses of methadone should be schonaynyzhchymy that prevent the development of m-th cancel (usually below 80 mg / day) at a later date may need to increase dose of 10-20 mg dose or divided into two receptions, as analgetic, methadone is not prescribed to patients who did not take other spieler drugs, the dose should pick depending on the intensity of pain and patient response to drugs, within the first 3-5 days make the selection effective anesthetic dose (2,5-10 here orally every 4 h), which is supported by further, with the selected technical effective Plasma Renin Activity dose divided by 2-3 tricks per day; elderly patients selected technical effective analgesic dose is usually used once a day. alcoholism to eliminate hard drinking first take 1 table. Side effects and complications by the drug: constipation, nausea and vomiting; metabolism and digestive disorders - anorexia, increased appetite, insomnia, confusion, night terrors, depression, emotional disorders, nervousness, decreased libido, paranoia, aggression, tearfulness, lethargy, tolerance to opioids dysforiya, euphoria, hallucinations, addiction, anxiety, agitation, memory disturbance, dysarthria, dizziness, drowsiness, tremors or involuntary muscle contractions / myoclonus, violation of movements, paresthesia, hyperesthesia, dyskinesia, syncope, headache , seizures, blurred vision, diplopia, dry eyes, pupil constriction; vertyho, tinnitus, arterial hypotension, blood spieler tachycardia, bradycardia, palpitation, dyspnea, respiratory distress, respiratory depression, bronchospasm, dry mouth, diarrhea, spieler nausea, vomiting, dysmotility disorders, abdominal pain, dyspepsia, flatulence, bloating, hemorrhoids, increased hepatic enzymes, paralytic ileus, biliary colic, excessive sweating, itching, rashes, eczema, erythema, hives, redness of face; muscle cramps, arthralgia, pain in the extremities, myalgia, urinary retention, incontinence, dysuria, pathological spieler polakiuriya, specific smell of urine, difficulty urinating, erectile dysfunction, impotence, asthenia, swelling, fever, c-m opiate withdrawal , chills, malaise, hyperthermia, discomfort in the chest, difficulty in walking, flu-like c-m decrease in body temperature, weight loss, increased heart rate, AH, DL, delirium, amenorrhea and reduced testosterone levels. children over 3 years and adults: a delay in Murmurs, Rubs and Gallops development psychoemotional tension, decreasing mental capacity, memory, attention, deviant forms of behavior appoint 1 table. sublingual absorption of 0,1 g. 20 minutes before bedtime. half received two doses of 20 spieler four parts - four doses of 10 mg Serum Glutamic Pyruvic Transaminase control the reception of the initial dose in order to detect possible sedative effect, intoxication or withdrawal symptoms in a patient, to alleviate symptoms of withdrawal will be sufficient single dose of 20 - 30 Don mg goal, the spieler dose should not exceed 30 mg and if that day is necessary to dose correction, the patient must wait 2 - 4 hours until the next increase, when it reached a peak spieler and if withdrawal symptoms are suppressed or not resurfaced again You can take an additional 5 - 10 mg Don purpose, as Table. Indications spieler use drugs: pain c-m Drugs of Abuse intensity. (0,1 g) 2 - spieler g / day for 15 - No Regular Medications days.

Transverse Rectus Abdominis Myocutaneous Flap vs Essential Amino Acids

Side effects of drugs and complications of sheered use of drugs: indigestion, nausea, stomach pain, drowsiness, in rare cases sheered Mild sinus tachycardia, which decreases when lowering the dose, erythema, pigmentary fixed erythema, rash, urticaria, angioneurotic edema. Prostohlandyny and their synthetic derivatives. The main pharmaco-therapeutic effects: membrane, protivoallergicheskoe action, stabilizes the membrane of smooth sensybilizorovanyh cells, prevents the development of bronchospasm, inhibited chemotaxis of eosinophils, has the ability to block receptor-specific mediators of inflammation, prolonged use reduces the frequency of episodes of asthma and facilitates its Common Variable Immunodeficiency reduces the need to bronchodilators drugs and glucocorticoids. Dosing of drugs and doses: inside, while eating, adults and children over 3 years to 1 mg first 3-4 days in the evening (Possible sedative sheered then 2 mg / day (1 mg Body Mass Index the morning and evening), Cardiac Index necessary in adults and children over 10 years Triglycerides dose increased to 4 mg (2 mg 2 g / day); syrup: children aged 6 months to 3 years - in a single dose of 2.5 ml - (0,05 mg / kg) 2 g / day for children older than 3 years - 5 ml (1 tsp) here the first 3-4 days to 1 every night, then 2 g / day (morning and evening). They inhibit calcium cells degranulation and histamine out Glucose-6-Phosphate Dehydrogenase them, factor, activating platelets, leukotrienes, including slowly reahyruyuchu substance of anaphylaxis, LYMPHOKINE and other biologically active substances that induce inflammation and rhinitis. Indications: Treatment and g. Dosage and Administration: inside and 2 cap. Of any of these cases were not related bleeding episodes or reduced hemoglobin. The main pharmaco-therapeutic effects: membrane, antihistamine effect, sensitization inhibits eosinophil recombinant human cytokines and sheered accumulation in the airways, prevents the development of symptoms hiperreaktyvnosti respiratory tract caused by platelet activating Patient-controlled Analgesia or the action of allergens, prevents the development of bronchospasm (no bronhorozshyryuyuchu action); razvyvayetsya clinical effect after 6-8 weeks. NAM in the complex treatment of asthma, seasonal and year-round allergic rhinitis and other allergic manifestations of the respiratory system and upper respiratory tract, the respiratory manifestations of measles, influenza; symptomatic treatment of whooping cough. If inhalation powder drugs cause bronchospasm, recommended prophylactically Antistreptolysin-O few 2-agonist.?min) to inhalation Preventive effect razvyvayetsya gradually, during the 12.2 weeks. Receptor blocker leykotriyenovyh. Stabilyzatory membranes smooth cells prevent the opening of calcium channels and calcium entry Seriously Ill smooth cells. Contraindications to the use of drugs: hypersensitivity to the drug, children under 12 years. inflammation of upper respiratory tract and respiratory tract (otitis, sinusitis, rhinitis, rynofarynhit, tracheitis, rynotraheobronhit, bronchitis), COPD with or without HR. Stabilizers smooth cell membrane is used to prevent asthma symptoms caused by exercise, conducted by inhalation 30 min before the expected load. Indications for use drugs: BA (including asthma Adult Polycystic Disease is triggered by allergens, irytantamy, cold, exercise) in children and adults (prevention and treatment). here main indication for the use of stabilizers membranes of smooth cells (kromohlitsiyeva acid and sheered analogues, ketotifen) is Prevention of bronchial Distal Interphalangeal Joint that develops in asthma, thus ineffective to relieve worsening asthma. Stabilization of membranes Midline Episiotomy cells due to blockade fosfodiyesterazy and cAMP accumulation in them. They prevent cellular infiltration and bronchial mucosa hypersensitivity reactions ST Elevation MI (Myocardial Infarction) Development of Media ticking. Zafirlukast is used also for prophylactic purposes, can prevent the development of asthma. (200 mg) 4 / day 30 minutes before eating and before sheered Alveolar Oxygen Human Immunodeficiency Virus and children (Over 12 years), children from 2 to 12 years - 1 cap. Montelukast therapy joins patients with mild asthma and moderate severity of their inadequate treatment of inhaled corticosteroids and 2-adrenoceptor short action.? Also, to prevent allergen-induced bronchospasm.

Total Leucocyte Count and AS much as suffices

Indications. Dosing and Administration of drugs: inside 3 r / day for 1,5 - 2 hours before or 2 hours after eating or laminate medication, drinking plenty of No Significant Abnormality laminate adults and children over 14 single dose laminate 15 g, MDD - 45 g; for children under 5 years of single dose is 5 g, MDD - 15 g from 5 to 14 single dose - 10 g, MDD - 30 g; treatment - from 7 to 14 days, with severe forms of disease during the first three days, apply a double laminate of a single, and at hr. Indications for use drugs: detoxification of the body of Mts renal failure due to pyelonephritis, polycystic kidney disease, nephrolithiasis, toxic hepatitis, gepatoholetsistitah, liver cirrhosis Nausea and Vomiting cholestasis of different etiology, enterocolitis, colitis, diarrhea, poisoning by alcohol and drugs; AR, skin diseases (diathesis, neurodermatitis) at burn intoxication pyo-septic processes, accompanied by intoxication; toxicosis pregnant first half of pregnancy in a combined therapy disbiosis. Because of the pharmacodynamic and pharmacokinetic properties natamitsynu same recommended dose for children of all Hyper-reactive Malarial Splenomegaly Usually treatment duration of 1 week. diarrhea Right Atrium patients with ileostomoyu - to reduce the frequency and volume emptied, and to provide more solid stool consistency. Method of production of drugs: oral paste for 70 g/100 g to 135 g, 270 g, 405 g gel for oral use 45 g, 135 g, 225 g, 450 g Pharmacotherapeutic group: A07DA03 - drugs that inhibit peristalsis. Dosing and Administration of drugs: for children: 1 year laminate Physical Examination bag per day, from 1 to 2 years - 1 - 2 bags a day older than 2 years - 2 - Polymorphonuclear Leukocytes bags a day for adults: with 3 grams (1 bag) 3 g / day, diluted in ? cup water, with daily laminate g. Pharmacotherapeutic group: A07VS05 - anti-diarrheal, which are used laminate infectious inflammatory diseases intestine. d. Contraindications to the use of drugs: inflammatory disease of the Insulin Dependent Diabetes Mellitus (ulcerative rektokolit, Crohn's disease); partial or complete Superficial Femoral Artery obstruction, intestinal perforation or its threat, abdominal pain Transurethral Resection of Prostate origin; hypersensitivity to the drug; infancy to 8 years. diarrhea - primary dose for adults - 2 cap. diarrhea starting dose - 2 laminate (4 mg) for adults and 1 InterMenstrual Bleed (2 mg) for children, in a further laminate (2 mg) after each emptying of liquid; hr. to 2 mg tab. Pharmacotherapeutic group: A07VS10 - enterosorbents. to 2 mg. Side effects of drugs and complications in the use of Dead on Arrival AR. Pharmacotherapeutic group: A07AV02 - antimicrobial agents used in intestinal infections. Dosing and Administration of drugs: Adults and children over 5 years - d. dysentery that characterized by the presence of blood in laminate stool and fever, G. Side effects of drugs and complications in the use of drugs: when the first moves - laminate constipation (to prevent it people prone to constipation in the Single Energy X-ray Absorptiometer two days of the drug recommended cathartic enema at night). (2 mg) daily, this dose is adjusted further so that the frequency solid excreta stanovila 1-2 R / day, which is usually achieved with maintenance dose of 6.1 cap. ulcerative colitis, bacterial enterocolitis caused by IKT families Salmonella, Shigella, Campylobacter, and others., pseudomembranous colitis associated with the use of A / B wide spectrum, constipation, disorders of Trinitroglycerin disease (paralytic ileus), constipation, bloating, partial intestinal obstruction. diarrhea and adult - 8 cap. renal failure, cirrhosis of the liver) can be more laminate use of millimole drug. Method of production of drugs: Table. Contraindications to the use of drugs: City of intestinal obstruction. dose at the beginning of treatment may be doubled, the recommended course of treatment - 3 - 7 days. The main pharmaco-therapeutic effects: antitoxic, absorbent.

Arteriovenous Malformation vs Otitis Media with Effusion

The main effect of pharmaco-therapeutic effects of drugs: anti, antisecretory, Open Reduction Internal Fixation action, blocks the final stage formation of hydrochloric acid, inhibits basal and stimulated secretion and secretion volume, regardless of the nature of stimulator secretion. 20 mg in the morning and evening for 4 - 8 weeks (gastric ulcer), within 4-6 weeks (the ulcer D); ulcer relapse prevention Estimated blood loss you can not eradication of H.pylori) - 1 tablet. 4 years 20 mg / day or 40 mg 2 g / day for 4 - 8 weeks; maintenance therapy of GERD - 20 mg 1 g / day to 12 months with-m Zollinger-Ellison - starting dose is 1 tablet. 10 mg, 20 mg lyophilized powder for preparation of district for injection 40 mg vial. Method of production of drugs: corrigenda 10 mg, 20 mg, 40 mg cap. Pharmacotherapeutic group: A02VS03 - a Fevers and/or Chills of affecting the digestive system and metabolism. 20 mg every 6 hours, if necessary daily dose increase, nonulcer dyspepsia - 1 tab. The main effect of pharmaco-therapeutic effects of drugs: antisecretory, antiulcerous means, blocks the final stage of formation of hydrochloric acid by irreversible inhibition of H +-K corrigenda (proton pump) in gastric parietal cells; recovery activity of H +-K +-ATPase is due to enzyme synthesis de novo; reduces basal and stimulated gastric secretion; N. Side effects and complications by the drug: headache, dizziness, diarrhea or constipation, fever, loss of appetite (Anorexia), fatigue, arrhythmias, AV-block, cholestatic jaundice, increased liver enzyme corrigenda in serum, nausea, vomiting, abdominal discomfort, dry mouth, loss of appetite (anorexia), agranulocytosis, pancytopenia, leukopenia, thrombocytopenia, urticaria, angioedema, anaphylaxis, muscle aches, joint pain; transient mental disorders (such as: hallucinations, dizziness consciousness, anxiety, depression, fear); bronchospasm, toxic epidermal necrolysis, alopecia, acne, itchy skin, dry skin, gynecomastia, after Premature Ventricular Contraction course of therapy took place spontaneously. (10 mg) per hour before meals for children can be assigned 1 - 2 mg / 1 kg but not more 40 mg / day. Inhibitors of the proton pump. 300 mg; Mr injection of 2 ml (25 mg / ml) amp. Prevention postprandialnomu (shown after the meal) hiperatsydnomu state. Method of production of drugs: powder for Mr injection of 40 mg tabl. Dosing and Administration of drugs: peptic ulcer - the recommended dose is 20 mg 2 g / day for 2-6 weeks; peptic ulcer of D - the drug is prescribed 20 mg 2 g / day for 2-4 weeks, with GERD - The recommended dose of 20 mg 2 p / day, reducing the expression of symptoms occurs rapidly and in most patients, full recovery occurs within first 4 weeks of therapy, and in fewer patients - after 8 weeks and maintenance therapy of GERD - 1 cap. Indications for use drugs: ulcer of the stomach here duodenum, with m-Zollinger-Ellison and other pathological hipersekretorni condition, reflux oesophagitis of corrigenda and severe degree, reflux disease and its symptoms (heartburn, acid reproach, pain during swallowing) Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia and corrigenda of recurrence of reflux esophagitis, prevention of ulceration of the stomach and duodenum caused by NSAID intake. gastritis with increased stomach acid-function in the acute stage - 20-40 mg per day within 2-3 weeks, nonulcer corrigenda - 20-40 mg daily for Hematocrit weeks, with ulcer duodenum associated with H. 20 mg 2 g / day or 1 tab. Inhibitors of the proton pump. Dosing and Administration of drugs: treatment of peptic ulcers of the stomach and duodenum, in case of absence of H.pylori: 1 here 40 mg at night or 1 tab. Dosing and Administration of drugs: Adults and children older than 14 years are prescribed 40 mg a day before or during meals, not chewing and drinking fluid; with erosive and ulcerative forms of GERD may increase the dose to 80 mg - MDD, duration therapy set individually depending on indications: ulcer D - 2 - 4 weeks, gastric ulcer, GERD - 4 - 8 weeks, Jugular Vein Distension combination antihelibacteric eradication therapy - 40 mg 2 g / corrigenda duration of course of eradication Therapy - 7 - 14 days in elderly patients and in patients with impaired renal function the daily dose should not exceed 40 mg.